Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008

Cancer Epidemiology

Volumn 38, Issue 1, 2014, Pages 28-34

  Pavlík, Tomáš ^a   Májek, Ondřej ^a   Büchler, Tomáš ^b   Vyzula, Rostislav ^c   Petera, Jiří ^d   Ryska, Miroslav ^e   Ryška, Aleš ^d   Cibula, David ^f   Babjuk, Marko ^g   Abrahámová, Jitka ^b   Vorlíček, Jiří ^c   Mužík, Jan ^a   Dušek, Ladislav ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^d UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^e CENTRAL MILITARY HOSPITAL   (Czech Republic)

^f CHARLES UNIVERSITY   (Czech Republic)

^g UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Cancer; Population based registry; Relative survival; Stage specific analysis

Indexed keywords

CANCER; POPULATION-BASED REGISTRY; RELATIVE SURVIVAL; STAGE-SPECIFIC ANALYSIS;

ADOLESCENT; ADULT; AGED; CZECH REPUBLIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS; REGISTRIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84894237401     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.11.002     Document Type: Article

References (34)

1. Berrino F., De Angelis R., Sant M., Rosso S., Bielska-Lasota M., Coebergh J.W., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007, 8(9):773-783.
2. Verdecchia A., Francisci S., Brenner H., Gatta G., Micheli A., Mangone L., et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007, 8(9):784-796.
3. Coleman M.P., Quaresma M., Berrino F., Lutz J.M., De Angelis R., Capocaccia R., et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008, 9(8):730-756.
4. Brenner H., Gondos A., Arndt V. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol 2007, 25(22):3274-3280.
5. Gondos A., Arndt V., Holleczek B., Stegmaier C., Ziegler H., Brenner H. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 2007, 121(2):395-400.
6. Gondos A., Bray F., Hakulinen T., Brenner H. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 2009, 20(3):564-573.
7. Rachet B., Woods L.M., Mitry E., Riga M., Cooper N., Quinn M.J., et al. Cancer survival in England and Wales at the end of the 20th century. Br J Cancer 2008, 99(Suppl 1):S2-S10.
8. Berrino F., Brown C., Moller T., Sobin L., Faivre J. ENCR recommendations - condensed TNM for coding the extent of disease 2002, European Network of Cancer Registries, Lyon.
9. Ederer F., Axtell L.M., Cutler S.J. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961, 6:101-121.
10. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982, 38(4):933-942.
11. HMD Human Mortality Database Berkeley (USA): University of California (USA) Max Planck Institute for Demographic Research (Germany) 2012, available from: www.mortality.org, accessed on 03.07.12.
12. Corazziari I., Quinn M., Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004, 40(15):2307-2316.
13. Brenner H., Soderman B., Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 2002, 31(2):456-462.
14. Dickman P.W., Sloggett A., Hills M., Hakulinen T. Regression models for relative survival. Stat Med 2004, 23(1):51-64.
15. Verdecchia A., Guzzinati S., Francisci S., De Angelis R., Bray F., Allemani C., et al. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 2009, 45(6):1042-1066.
16. Dusek L., et al. Czech Cancer Care in numbers 2008-2009 2009, Grada Publishing, a.s, Praha.
17. Robinson D., Sankila R., Hakulinen T., Moller H. Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer 2007, 43(5):909-913.
18. de Vries E., Karim-Kos H.E., Janssen-Heijnen M.L., Soerjomataram I., Kiemeney L.A., Coebergh J.W. Explanations for worsening cancer survival. Nat Rev Clin Oncol 2010, 7(1):60-63.
19. IHIS. Binding instructions of the National Health Information System (NHIS): Czech National Cancer Registry-instruction for the contents of data structure, version 051-20060101/2 2006, Institute of Health Information and Statistics of the Czech Republic (IHIS), Prague.
20. IHIS Cancer incidence 2008 in the Czech Republic 2008, Institute of Health Information and Statistics of the Czech Republic (IHIS), Prague.
21. Pollock A.M., Vickers N. The impact on colorectal cancer survival of cases registered by 'death certificate only': implications for national survival rates. Br J Cancer 1994, 70(6):1229-1231.
22. Hiripi E., Gondos A., Emrich K., Holleczek B., Katalinic A., Luttmann S., et al. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol 2012, 23(2):472-479.
23. Morris E.J., Sandin F., Lambert P.C., Bray F., Klint A., Linklater K., et al. A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut 2011, 60(8):1087-1093.
24. Majek O., Danes J., Zavoral M., Dvorak V., Suchanek S., Seifert B., et al. Czech National Cancer Screening Programmes in 2010. Klin Onkol 2010, 23(5):343-353.
25. Majek O., Danes J., Skovajsova M., Bartonkova H., Buresova L., Klimes D., et al. Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme. BMC Public Health 2011, 11:288.
26. Dickman P.W., Adami H.O. Interpreting trends in cancer patient survival. J Intern Med 2006, 260(2):103-117.
27. Dinan M.A., Curtis L.H., Carpenter W.R., Biddle A.K., Abernethy A.P., Patz E.F., et al. Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003. J Clin Oncol 2012, 30(22):2725-2730.
28. Misono S., Rue T., Rajendran J., Davis G.E. Effects of upstaging from PET scan on survival in head and neck squamous cell carcinoma. Head Neck 2010, 32(10):1283-1287.
29. Kong S.H., Lee H.J., Ahn H.S., Kim J.W., Kim W.H., Lee K.U., et al. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Ann Surg 2012, 255(1):50-58.
30. Benson J.R., Jatoi I., Keisch M., Esteva F.J., Makris A., Jordan V.C. Early breast cancer. Lancet 2009, 373(9673):1463-1479.
31. Gallagher D.J., Kemeny N. Metastatic colorectal cancer: from improved survival to potential cure. Oncology 2010, 78(3-4):237-248.
32. Holleczek B., Arndt V., Stegmaier C., Brenner H. Trends in breast cancer survival in Germany from 1976 to 2008 - a period analysis by age and stage. Cancer Epidemiol 2011, 35(5):399-406.
33. Majek O., Gondos A., Jansen L., Emrich K., Holleczek B., Katalinic A., et al. Survival from colorectal cancer in Germany in the early 21st century. Br J Cancer 2012, 106(11):1875-1880.
34. Lemmens V., van Steenbergen L., Janssen-Heijnen M., Martijn H., Rutten H., Coebergh J.W. Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival. Acta Oncol 2010, 49(6):784-796.